EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents

Aitor Carneiro, Sandra Barreiro, Claudia Sofia Machado, Miguel Pinto, Daniel Chavarria, Manuel Novás, Davide Crucitti, Carlos Fernandes, Maria João Matos iD

ChemMedChem · 2026-05-27 · 21 (10)

DOI: 10.1002/cmdc.70307 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-05-18. Written by Aitor Carneiro and 8 co-authors. Institution: Departamento Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, Santiago de Compostela, Spain. Major MEDLINE topics: Coumarins, Neuroprotective Agents, Drug Design, Indans. Cited 2 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Foundation for Science and Technology (FCT) and FEDER/COMPETE, Xunta de Galicia, Fundação para a Ciência e a Tecnologia.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

The design of hybrid molecules with multifunctional profiles has emerged as a promising strategy in medicinal chemistry, particularly for tackling complex disorders such as neurodegenerative diseases. There is an urgent need for therapeutic agents capable of acting on multiple pathological targets to both control neuronal death and support the recovery of already compromised neuronal populations. In this study, we synthesized and evaluated a series of hybrid compounds combining a coumarin scaffold with an alkynylamine moiety inspired by rasagiline. These molecules were studied for their potential as human monoamine oxidase ( h MAO) inhibitors, antioxidants, and neuroprotective agents. Five compounds demonstrated inhibitory activity against h MAO‐B in the micromolar range, along with significant neuroprotective effects against oxidative stress induced by Fe 3+ (FeNTA), tert ‐butyl hydroperoxide ( t ‐BHP), and hydrogen peroxide (H 2 O 2 ). Additionally, all compounds exhibited the ability to scavenge free radicals (ABTS assay) and chelate Fe(II), further corroborating their antioxidant capacity. In addition, the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties were investigated. Docking studies and molecular dynamics simulations provide additional support for the experimental data. Collectively, these findings provide renewed evidence for the therapeutic potential of coumarin‐rasagiline hybrids as multifunctional agents for the treatment of neurodegenerative diseases.

Subjects

MeSH terms (MEDLINE)

CoumarinsNeuroprotective AgentsDrug DesignIndansMonoamine Oxidase InhibitorsHumansMonoamine OxidaseStructure-Activity RelationshipMolecular Docking SimulationOxidative StressMolecular StructureHydrogen PeroxideAntioxidantsDose-Response Relationship, DrugAnimals

Author keywords

coumarinhuman monoamine oxidasehybrid compoundsneurodegenerative diseasesneuroprotectionrasagiline

Substances

CoumarinsrasagilineNeuroprotective AgentsIndansMonoamine Oxidase InhibitorsMonoamine OxidasecoumarinHydrogen PeroxideAntioxidants

Authors and institutions

  • Departamento Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.
  • Associate Laboratory i4HB - Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • UCIBIO - Applied Molecular Biosciences Unit, REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  • RISE-Health, Faculty of Medicine, University of Porto, Porto, Portugal.
  • Group of Computational Genomics and Hematology (GreCoXen), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

ORCID profiles: Maria João Matos

Funding

  • Foundation for Science and Technology (FCT) and FEDER/COMPETE
  • Xunta de Galicia
  • Fundação para a Ciência e a Tecnologia

Cite

APA

Carneiro, A., Barreiro, S., Machado, C. S., Pinto, M., Chavarria, D., Novás, M., Crucitti, D., Fernandes, C., & Matos, M. J. (2026). Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents. ChemMedChem, 21(10). https://doi.org/10.1002/cmdc.70307

Vancouver

Carneiro A, Barreiro S, Machado CS, Pinto M, Chavarria D, Novás M, et al. Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents. ChemMedChem. 2026;21(10). doi:10.1002/cmdc.70307

BibTeX
@article{Carneiro2026,
  author = {Carneiro, Aitor and Barreiro, Sandra and Machado, Claudia Sofia and Pinto, Miguel and Chavarria, Daniel and Novás, Manuel and Crucitti, Davide and Fernandes, Carlos and Matos, Maria João},
  title = {Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {10},
  doi = {10.1002/cmdc.70307}
}
Start for free →